ArticleBMC cardiovascular disorders2026
Comparison of different criteria for rheumatic heart disease screening: an empirical study in Sierra Leone.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundRheumatic heart disease (RHD) affects approximately 40 million people, primarily in low- and middle-income countries. Transthoracic echocardiography is the gold standard for early detection of RHD. Yet, no single echocardiographic finding or combination of findings unequivocally confirms RHD, especially in subclinical stages. As a result, multiple diagnostic guidelines have been proposed.
objectivesTo characterise the echocardiographic RHD findings and criteria included in five of those guidelines; to assess how these diagnostic criteria differ when applied to a concrete population, namely a cohort of high-school students in Sierra Leone; and, as a secondary objective, to provide an initial estimate of the burden of RHD in this country.
methodsOur study has two parts. First, we performed a qualitative comparison of five major echocardiographic guidelines, mapping every diagnostic criterion into four roles (required, sufficient, combined, or not considered) for each guideline. Second, we conducted a school-based screening in Sierra Leone. A cohort of 604 asymptomatic female students (aged 10–22 years) underwent a two-phase echocardiographic protocol. We quantified regurgitant jet characteristics and morphological signs according to the criteria of the compared guidelines.
resultsGuideline discrepancies were substantial, particularly in jet length thresholds and the diagnostic role of morphological features. These differences shifted individual classifications across categories. In our cohort, 13 students (2.2%) had findings beyond normal under at least one guideline, and positive cases ranged from 0.99% to 2.15% depending on the guideline. Using the World Heart Federation (WHF) 2023 criteria, 1.16% (95% CI: 0.47–2.37) were classified as positive.
conclusionsVariability in echocardiographic criteria influences RHD classification and prevalence estimation. Our empirical study shows that the use of rigid echocardiographic cut-offs may lead to discarding some cases suspicious of RHD, especially in the WHF 2023 screening guideline, because one unfulfilled criterion automatically leads to a negative diagnosis, regardless of the number and relevance of positive findings. We argue that a probabilistic causal model that ponders the numerical measurements and considers correlations among findings would be more appropriate for screening and diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.